Qube Research & Technologies (QRT)
MED icon

Qube Research & Technologies (QRT)’s Medifast MED Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-58,166
Closed -$1.11M – 3691
2024
Q3 		$1.11M Sell
58,166
-119,054
-67% -$2.29M ﹤0.01% 1992
2024
Q2 		$3.87M Buy
177,220
+121,469
+218% +$3.24M 0.01% 1373
2024
Q1 		$2.14M Buy
55,751
+52,580
+1,658% +$2.55M ﹤0.01% 1714
2023
Q4 		$213K Buy
+3,171
New +$221K ﹤0.01% 2758
2023
Q2 		– Sell
-11,004
Closed -$1.14M – 2759
2023
Q1 		$1.14M Buy
+11,004
New +$1.22M ﹤0.01% 1238
2022
Q3 		– Sell
-8,059
Closed -$1.46M – 2807
2022
Q2 		$1.46M Buy
8,059
+3,325
+70% +$595K 0.01% 950
2022
Q1 		$808K Buy
4,734
+1,541
+48% +$291K 0.01% 1283
2021
Q4 		$669K Sell
3,193
-1,921
-38% -$397K 0.01% 1420
2021
Q3 		$985K Buy
5,114
+726
+17% +$178K 0.01% 914
2021
Q2 		$1.24M Sell
4,388
-965
-18% -$261K 0.01% 861
2021
Q1 		$1.13M Buy
+5,353
New +$1.28M 0.02% 800
2020
Q4 		– Sell
-3,237
Closed -$532K – 2048
2020
Q3 		$532K Buy
+3,237
New +$533K 0.01% 1016
2020
Q1 		– Sell
-4,059
Closed -$445K – 1447
2019
Q4 		$445K Buy
+4,059
New +$393K 0.01% 1014

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MED Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Medifast (MED) in Q4 2024, closing a stake of 58,166 shares — an estimated $1.11M sold.

Qube Research & Technologies (QRT) first reported a position in MED in Q4 2019 and held it in 13 quarters. The position peaked at $3.87M in Q2 2024. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 58,166 Medifast shares in Q4 2024, an estimated $1.11M.
  • Qube Research & Technologies (QRT) first reported a position in Medifast in Q4 2019 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Medifast position peaked at $3.87M in Q2 2024.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.